falsefalse

Post-Conference Perspectives: Understanding HER2-Low Breast Cancer - Episode 1

Current Landscape of HER2 Testing in Breast Cancer

,

Shared insight on the current state of HER2 classification and testing and in breast cancer, with respect to how it may influence future treatment approaches.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
    Now Viewing
    EP. 1: Current Landscape of HER2 Testing in Breast Cancer
    EP. 2: Strategies in Identifying and Stratifying HER2 Status in Breast Cancer
    EP. 3: Treating HER2-low Breast Cancer With Novel Antibody Drug Conjugates
    EP. 4: HER2-low Breast Cancer: Practical Applications of ADC Therapy

    Related Content:

    Post-Conference Perspectives: Understanding HER2-Low Breast CancerBreast Cancer
    Early Insights from ASCO 2025: Press Briefing Highlights with Clinical Impact
    Inavolisib Plus Palbociclib/Fulvestrant Earns Positive CHMP Opinion for PIK3CA-Mutated, ER+/HER2– Advanced Breast Cancer
    Researchers Address the Barriers to Remote Breast Cancer Symptom Monitoring in the US
    x